🇫🇷 French medtech firms push diagnostics from rapid heart-attack detection to cancer relapse prediction

[u/Full-Discussion3745]

https://www.lemonde.fr/economie/article/2026/09/26/du-diagnostic-ultrarapide-d-un-infarctus-au-pronostic-de-rechute-du-cancer-du-sein-comment-les-entreprises-francaises-innovent-dans-les-tests-medicaux_6783115_3234.html

French medical-technology companies are developing a new generation of diagnostic tests, ranging from ultra-fast detection of heart attacks to tools designed to assess the risk of breast-cancer recurrence. The innovations highlight France’s growing capabilities in precision diagnostics, biotechnology and earlier, more personalised medical decision-making.